Evidence map›Paper›PMID 27421950›Full record

ArticleStem cells translational medicine2016

Functional Maturation of Induced Pluripotent Stem Cell Hepatocytes in Extracellular Matrix-A Comparative Analysis of Bioartificial Liver Microenvironments.

Bo Wang, Adam E Jakus, Pedro M Baptista, Shay Soker, Alejandro Soto-Gutierrez, Michael M Abecassis, Ramille N Shah, Jason A Wertheim

Open access · goldAbstract readComparative Study
In one paragraph

Article in Stem cells translational medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Bo WangComprehensive Transplant Center, Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Adam E JakusQuerrey Institute for BioNanotechnology, Northwestern University, Chicago, Illinois, USA Department of Materials Science and Engineering, Northwestern University, Evanston, Illinois, USA.
Pedro M BaptistaInstituto de Investigación Sanitaria de Aragón, Centro de Investigación Biomédica de Aragón, Zaragoza, Spain Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas (CIBERehd), Zaragoza, Spain Fundacion ARAID, Zaragoza, Spain.
Shay SokerWake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Alejandro Soto-GutierrezDepartment of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA Department of Pathology, Thomas E. Starzl Transplantation Institute, and McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Michael M AbecassisComprehensive Transplant Center, Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA Department of Surgery, Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Ramille N ShahComprehensive Transplant Center, Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA Querrey Institute for BioNanotechnology, Northwestern University, Chicago, Illinois, USA Department of Materials Science and Engineering, Northwestern University, Evanston, Illinois, USA Department of Surgery, Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA Department of Biomedical Engineering, Northwestern University, Evanston, Illinois, USA.
Jason A WertheimComprehensive Transplant Center, Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA Querrey Institute for BioNanotechnology, Northwestern University, Chicago, Illinois, USA Department of Surgery, Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA Department of Biomedical Engineering, Northwestern University, Evanston, Illinois, USA Department of Surgery, Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois, USA Chemistry of Life Processes Institute, Northwestern University, Evanston, Illinois, USA jason.wertheim@northwestern.edu.
Northwestern University · USCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESJesse Brown VA Medical Center · USUniversity of Pittsburgh · USWake Forest University · US

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
Optimization and control of hepatocyte activity via biofunctional modificationK08DK101757 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WERTHEIM, JASON A · 2014 to 2018
$777k
Multifunctional Printed Scaffolds for Enhancing Hepatocyte Viability and FunctionK01DK099454 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SHAH, RAMILLE N · 2013 to 2017
$652k
NCI NIH HHS P30 CA060553NIDDK NIH HHS K01 DK099454NIDDK NIH HHS K08 DK101757
6 · The paper itself

Abstract

unlabelled: Induced pluripotent stem cells (iPSCs) are new diagnostic and potentially therapeutic tools to model disease and assess the toxicity of pharmaceutical medications. A common limitation of cell lineages derived from iPSCs is a blunted phenotype compared with fully developed, endogenous cells. We examined the influence of novel three-dimensional bioartificial microenvironments on function and maturation of hepatocyte-like cells differentiated from iPSCs and grown within an acellular, liver-derived extracellular matrix (ECM) scaffold. In parallel, we also compared a bioplotted poly-l-lactic acid (PLLA) scaffold that allows for cell growth in three dimensions and formation of cell-cell contacts but is infused with type I collagen (PLLA-collagen scaffold) alone as a "deconstructed" control scaffold with narrowed biological diversity. iPSC-derived hepatocytes cultured within both scaffolds remained viable, became polarized, and formed bile canaliculi-like structures; however, cells grown within ECM scaffolds had significantly higher P450 (CYP2C9, CYP3A4, CYP1A2) mRNA levels and metabolic enzyme activity compared with iPSC hepatocytes grown in either bioplotted PLLA collagen or Matrigel sandwich control culture. Additionally, the rate of albumin synthesis approached the level of primary cryopreserved hepatocytes with lower transcription of fetal-specific genes, α-fetoprotein and CYP3A7, compared with either PLLA-collagen scaffolds or sandwich culture. These studies show that two acellular, three-dimensional culture systems increase the function of iPSC-derived hepatocytes. However, scaffolds derived from ECM alone induced further hepatocyte maturation compared with bioplotted PLLA-collagen scaffolds. This effect is likely mediated by the complex composition of ECM scaffolds in contrast to bioplotted scaffolds, suggesting their utility for in vitro hepatocyte assays or drug discovery. SIGNIFICANCE: Through the use of novel technology to develop three-dimensional (3D) scaffolds, the present study demonstrated that hepatocyte-like cells derived via induced pluripotent stem cell (iPSC) technology mature on 3D extracellular matrix scaffolds as a result of 3D matrix structure and scaffold biology. The result is an improved hepatic phenotype with increased synthetic and catalytic potency, an improvement on the blunted phenotype of iPSC-derived hepatocytes, a critical limitation of iPSC technology. These findings provide insight into the influence of 3D microenvironments on the viability, proliferation, and function of iPSC hepatocytes to yield a more mature population of cells for cell toxicity studies and disease modeling.

Indexed as

Liver, ArtificialTissue ScaffoldsAnimalsCell Culture TechniquesExtracellular MatrixHepatocytesHumansImmunohistochemistryInduced Pluripotent Stem CellsMaleMicroscopy, ElectronPolyestersRatsRats, Sprague-DawleyReverse Transcriptase Polymerase Chain ReactionTissue EngineeringPolyesterspoly(lactide)Induced pluripotent stem cellsLiverStem cell-microenvironment interactionsStem/progenitor cellTissue regeneration

Identifiers

PMID27421950
PMCPMC4996436
OpenAlexW2470369424

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.